Back
Summit Therapeutics Stock Price Chart
Sponsored
SMMT
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
74
SMMT
Summit Therapeutics
Last Price:
24.34
Seasonality Move:
26.72%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is moderately bullish and SMMT is experiencing slight buying pressure.
Summit Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.23 | Sell |
20-day SMA: | 19 | Buy |
50-day SMA: | 13.97 | Buy |
200-day SMA: | 6.94 | Buy |
8-day EMA: | 24.24 | Buy |
20-day EMA: | 20.51 | Buy |
50-day EMA: | 15.51 | Buy |
200-day EMA: | 8.51 | Buy |
Summit Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.83 | Buy |
Relative Strength Index (14 RSI): | 62.93 | Buy |
Chaikin Money Flow: | 4296288 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.22 - 24.22) | Buy |
Bollinger Bands (100): | (4.41 - 16.03) | Buy |
Summit Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 24.39 while SMMT 8-day simple moving average is 26.23, which is a Sell signal.
- The stock price of SMMT is 24.39 while Summit Therapeutics 20-day SMA is 19.00, which makes it a Buy.
- Summit Therapeutics 50-day simple moving average is 13.97 while SMMT share price is 24.39, making it a Buy technically.
- SMMT stock price is 24.39 and Summit Therapeutics 200-day simple moving average is 6.94, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Buy
74
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a Buy
The current Summit Therapeutics [SMMT] share price is $24.39. The Score for SMMT is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
Summit Therapeutics Stock Info
Market Cap:
17.92B
Price in USD:
24.39
Share Volume:
9.83M
Summit Therapeutics 52-Week Range
52-Week High:
33.89
52-Week Low:
1.64
Buy
74
Summit Therapeutics (SMMT)
is a Buy
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?
The Summit Therapeutics stock price is 24.39 USD today. -
Will SMMT stock go up or go down?
Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Summit Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is not overvalued.
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 24.39 while SMMT 8-day exponential moving average is 24.24, which is a Buy signal.
- The stock price of SMMT is 24.39 while Summit Therapeutics 20-day EMA is 20.51, which makes it a Buy.
- Summit Therapeutics 50-day exponential moving average is 15.51 while SMMT share price is 24.39, making it a Buy technically.
- SMMT stock price is 24.39 and Summit Therapeutics 200-day simple moving average is 8.51, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
- SMMT Moving Average Covergence Divergence (MACD) indicator is 3.83, suggesting Summit Therapeutics is a Buy
- Summit Therapeutics Relative Strength Index (RSI) is 62.93, which suggest Summit Therapeutics is overbought
- The Bollinger Bands (25) for Summit Therapeutics is (11.22 - 24.22), which suggest Summit Therapeutics is a Buy
- The Bollinger Bands (100) for Summit Therapeutics is (4.41 - 16.03), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.